In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Call for applications for EC health action programme

This article was originally published in Clinica

Executive Summary

The European Commission has issued a call for applications for its second programme of Community action in the field of health (2008-13). This call for applications consists of the following parts: a call for proposals for the award of a financial contribution to specific actions in the form of projects; a call for proposals for the award of a financial contribution to specific actions in the form of conferences; a call for proposals for the award of a financial contribution to the functioning of non governmental bodies and specialised networks (operating grants); and an invitation to member states and participating countries for submission of joint actions. The deadline for submissions of the proposals under each call is May 23, 2008. Information on the programme can be obtained at: http://ec.europa.eu.phea

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT046441

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel